OBJECTIVE: To test the efficacy of a training course on the diagnosis and treatment of schizophrenia, tailored for the general practitioner. METHOD: A course, in a 3-session format, was given to 215 primary care doctors from the city of Brescia and its province, in Italy. All 706 doctors working in primary care were asked to participate. Of these doctors, 30.5% took part in the study. The first session (215 doctors) assessed baseline knowledge of schizophrenia (June 2002), the second (173 doctors) gave formal teaching and assessed post-lesson knowledge (October 2002), and the third (130 doctors) evaluated the retention of knowledge after 8 months (July 2003). The main outcome measures were total number of schizophrenia symptoms identified, total number of antipsychotics identified, and knowledge about antipsychotic-related adverse events. RESULTS: Post-lesson, general practitioners could identify 6.5 more symptoms (p < .001) and 4.9 more antipsychotics (p < .001). Compared to baseline, 71.5% vs. 15.4% of doctors had a good knowledge of antipsychotic-related adverse events. Although a loss of knowledge was found after the 8-month follow-up, knowledge at the endpoint was significantly higher than at baseline for the 3 main outcome variables (p < .001). CONCLUSION: The teaching course on schizophrenia for general practitioners was effective, and the knowledge gained after teaching was stable across time.
OBJECTIVE: To test the efficacy of a training course on the diagnosis and treatment of schizophrenia, tailored for the general practitioner. METHOD: A course, in a 3-session format, was given to 215 primary care doctors from the city of Brescia and its province, in Italy. All 706 doctors working in primary care were asked to participate. Of these doctors, 30.5% took part in the study. The first session (215 doctors) assessed baseline knowledge of schizophrenia (June 2002), the second (173 doctors) gave formal teaching and assessed post-lesson knowledge (October 2002), and the third (130 doctors) evaluated the retention of knowledge after 8 months (July 2003). The main outcome measures were total number of schizophrenia symptoms identified, total number of antipsychotics identified, and knowledge about antipsychotic-related adverse events. RESULTS: Post-lesson, general practitioners could identify 6.5 more symptoms (p < .001) and 4.9 more antipsychotics (p < .001). Compared to baseline, 71.5% vs. 15.4% of doctors had a good knowledge of antipsychotic-related adverse events. Although a loss of knowledge was found after the 8-month follow-up, knowledge at the endpoint was significantly higher than at baseline for the 3 main outcome variables (p < .001). CONCLUSION: The teaching course on schizophrenia for general practitioners was effective, and the knowledge gained after teaching was stable across time.
Authors: Itzhak Levav; Robert Kohn; Ivan Montoya; Carlos Palacio; Pablo Rozic; Ida Solano; Willians Valentini; Benjamin Vicente; Jorge Castro Morales; Francisco Espejo Eigueta; Yamini Saravanan; Claudio T Miranda; Norman Sartorius Journal: Psychol Med Date: 2005-01 Impact factor: 7.723
Authors: Vaughan J Carr; Terry J Lewin; Rosemary E Barnard; Jane M Walton; Jennifer L Allen; Paul M Constable; Jenny L Chapman Journal: Acta Psychiatr Scand Date: 2002-05 Impact factor: 6.392